(NP (NP (NN Aim)) (: :) (S (VP (TO To) (VP (VB review) (SBAR (WHADVP (WRB how)) (S (NP (NP (NN machine) (NN learning)) (PRN (-LRB- -LRB-) (NP (NNP ML)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN applied) (PP (TO to) (NP (NP (VBG imaging) (NNS biomarkers)) (PP (IN in) (NP (NN neuro-oncology))))) (, ,) (PP (IN in) (ADJP (JJ particular))) (PP (IN for) (NP (NP (NN diagnosis)) (, ,) (NP (NN prognosis)) (, ,) (CC and) (NP (NN treatment) (NN response) (NN monitoring))))))))))) (. .))
(NP (NP (NNS Materials) (CC and) (NNS Methods)) (: :) (S (NP (DT The) (NNP PubMed) (CC and) (NNP MEDLINE) (NNS databases)) (VP (VBD were) (VP (VBN searched) (PP (IN for) (NP (NP (NNS articles)) (VP (VBN published) (PP (IN before) (NP (NNP September) (CD 2018)))))) (S (VP (VBG using) (NP (JJ relevant) (NN search) (NNS terms))))))) (. .))
(S (NP (DT The) (NN search) (NN strategy)) (VP (VBD focused) (PP (IN on) (NP (NP (NNS articles)) (VP (VBG applying) (NP (NNP ML)) (PP (TO to) (NP (VB high-grade) (NN glioma) (NNS biomarkers))) (PP (IN for) (NP (NP (NN treatment) (NN response) (NN monitoring)) (, ,) (NP (NN prognosis)) (, ,) (CC and) (NP (NN prediction)))))))) (. .))
(NP (NP (NNS Results)) (: :) (S (NP (NP (JJ Magnetic) (NN resonance) (NN imaging)) (PRN (-LRB- -LRB-) (NP (NNP MRI)) (-RRB- -RRB-))) (VP (VBZ is) (ADVP (RB typically)) (VP (VBN used) (PP (IN throughout) (NP (DT the) (NN patient) (NN pathway))) (SBAR (IN because) (S (S (NP (JJ routine) (JJ structural) (VBG imaging)) (VP (VBZ provides) (NP (JJ detailed) (ADJP (JJ anatomical) (CC and) (JJ pathological)) (NN information)))) (CC and) (S (NP (VBD advanced) (NNS techniques)) (VP (VBP provide) (NP (JJ additional) (JJ physiological) (NN detail))))))))) (. .))
(S (S (VP (VBG Using) (NP (ADJP (RB carefully) (VBN chosen)) (NN image) (NNS features)))) (, ,) (NP (NNP ML)) (VP (VBZ is) (ADVP (RB frequently)) (VP (VBN used) (S (VP (TO to) (VP (VB allow) (NP (JJ accurate) (NN classification)) (PP (IN in) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS scenarios)))))))))) (. .))
(S (PP (RB Rather) (IN than) (S (VP (VBG being) (VP (VBN chosen) (PP (IN by) (NP (JJ human) (NN selection))))))) (, ,) (NP (NNP ML)) (ADVP (RB also)) (VP (VBZ enables) (S (NP (NN image) (NNS features)) (VP (TO to) (VP (VB be) (VP (VBN identified) (PP (IN by) (NP (DT an) (NN algorithm)))))))) (. .))
(S (NP (JJ Much) (NN research)) (VP (VBZ is) (VP (VBN applied) (PP (TO to) (S (VP (VBG determining) (NP (NP (JJ molecular) (NNS profiles)) (, ,) (NP (JJ histological) (NN tumour) (NN grade)) (, ,) (CC and) (NP (NN prognosis))) (S (VP (VBG using) (NP (NP (NNP MRI) (NNS images)) (VP (VBD acquired) (PP (IN at) (NP (NP (DT the) (NN time)) (SBAR (WHNP (WDT that)) (S (NP (NNS patients)) (ADVP (JJ first)) (VP (JJ present) (PP (IN with) (NP (DT a) (NN brain) (NN tumour))))))))))))))))) (. .))
(S (S (VP (VBG Differentiating) (NP (DT a) (NN treatment) (NN response)) (PP (IN from) (NP (DT a) (JJ post-treatment-related) (NN effect))) (S (VP (VBG using) (NP (NN imaging)))))) (VP (VBZ is) (UCP (ADJP (RB clinically) (JJ important)) (CC and) (ADVP (RB also)) (NP (NP (NP (DT an) (NN area)) (PP (IN of) (NP (JJ active) (NN study)))) (PRN (-LRB- -LRB-) (VP (VBN described) (ADVP (RB here)) (PP (IN in) (NP (NP (CD one)) (PP (IN of) (NP (NP (CD two) (JJ Special) (NNP Issue) (NNS publications)) (VP (VBD dedicated) (PP (TO to) (NP (NP (DT the) (NN application)) (PP (IN of) (NP (NNP ML))) (PP (IN in) (NP (NN glioma) (NN imaging))))))))))) (-RRB- -RRB-))))) (. .))
(NP (NP (NN Conclusion)) (: :) (S (SBAR (IN Although) (FRAG (NP (NN pioneering)))) (, ,) (NP (NP (JJS most)) (PP (IN of) (NP (DT the) (NN evidence)))) (VP (VBZ is) (PP (IN of) (NP (DT a) (JJ low) (NN level))) (, ,) (S (VP (VBG having) (VP (VBN been) (VP (VBN obtained) (ADVP (ADVP (RB retrospectively)) (CC and) (PP (IN in) (NP (JJ single) (NNS centres)))))))))) (. .))
(S (NP (NP (NNS Studies)) (VP (VBG applying) (NP (NNP ML)) (S (VP (TO to) (VP (VB build) (NP (JJ neuro-oncology) (NN monitoring) (NN biomarker) (NNS models))))))) (VP (VBP have) (ADVP (RB yet)) (S (VP (TO to) (VP (VB show) (NP (NP (DT an) (JJ overall) (NN advantage)) (PP (IN over) (NP (NP (DT those)) (VP (VBG using) (NP (JJ traditional) (JJ statistical) (NNS methods)))))))))) (. .))
(S (S (NP (NP (NNP Development) (CC and) (NN validation)) (PP (IN of) (NP (NP (NNP ML) (NNS models)) (VP (VBN applied) (PP (TO to) (NP (JJ neuro-oncology))))))) (VP (NN require) (NP (JJ large) (, ,) (JJ well-annotated) (NNS datasets)))) (, ,) (CC and) (ADVP (RB therefore)) (S (NP (ADJP (JJ multidisciplinary) (CC and) (JJ multi-centre)) (NNS collaborations)) (VP (VBP are) (ADJP (JJ necessary)))) (. .))
